Polianta Ltd’s Horizon Therapeutics HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
– Sell
-33,500
Closed -$1.21M – 109
2019
Q4
$1.21M Sell
33,500
-15,200
-31% -$466K 0.74% 18
2019
Q3
$1.33M Buy
48,700
+9,700
+25% +$251K 0.84% 9
2019
Q2
$938K Buy
+39,000
New +$989K 0.4% 69

Other funds holding HZNP

Polianta Ltd's HZNP Position: Q1 2020 in Review

Polianta Ltd sold out of Horizon Therapeutics (HZNP) in Q1 2020, closing a stake of 33,500 shares — an estimated $1.21M sold.

Polianta Ltd first reported a position in HZNP in Q2 2019 and held it in 3 quarters. The position peaked at $1.33M in Q3 2019. 295 funds tracked by Wall St. Rank hold HZNP as of Q1 2020.

  • Polianta Ltd reported no remaining Horizon Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Polianta Ltd sold 33,500 Horizon Therapeutics shares in Q1 2020, an estimated $1.21M.
  • Polianta Ltd first reported a position in Horizon Therapeutics in Q2 2019 and held it in 3 quarters.
  • Polianta Ltd's Horizon Therapeutics position peaked at $1.33M in Q3 2019.
  • 295 funds tracked by Wall St. Rank held Horizon Therapeutics as of Q1 2020.

Based on Polianta Ltd's 13F filing for Q1 2020, filed 7 Apr 2020.